In Brief: Merck Proscar
Executive Summary
Merck Proscar: Indications to reduce the risk of acute urinary retention and to reduce the risk of the need for surgery (including transurethral resection of the prostate and prostatectomy) are approved for finasteride March 20. NDA supplement 20-180/S-016 for surgery risk reduction received a priority review...